Concepedia

Massimo Catarini

MC

Statistics

Publications

17

Citations

584

H-Index

16

Active since

2004

Affiliations

University of Macerata(Current)

Azienda Ospedaliero Universitaria Ospedali Riuniti

Ospedali Riuniti di Ancona

San Salvatore Hospital

Marche Polytechnic University

Massimo Catarini is an author at University of Macerata specializing in oncology, hematology, and pharmacotherapy.

Top concepts

Publications per year

2004–2016

17

Publications

17

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Massimo Offidani, Laura Corvatta, Monica Marconi et al. · PubMed · 2006 · 78 citations

, , +16

Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA

Attilio Olivieri, Guido Gini, Caterina Bocci et al. · The Oncologist · 2012 · 62 citations · Full text

Common and rare side‐effects of low‐dose thalidomide in multiple myeloma: focus on the dose‐minimizing peripheral neuropathy

Massimo Offidani, Laura Corvatta, Monica Marconi et al. · European Journal Of Haematology · 2004 · 51 citations

R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: A pilot study

Giuseppe Visani, Felicetto Ferrara, Francesco Alesiani et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 50 citations

Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma

Massimo Offidani, Claudia Polloni, Federica Cavallo et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 44 citations

, , +17

1–5 of 17